13,014 Shares in CME Group Inc. $CME Bought by Osmosis Investment Management UK Ltd

Osmosis Investment Management UK Ltd bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, Holdings Channel.com reports. The firm bought 13,014 shares of the financial services provider’s stock, valued at approximately $2,874,000.

Several other institutional investors also recently bought and sold shares of CME. Whipplewood Advisors LLC increased its holdings in shares of CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in CME Group in the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group in the 4th quarter worth approximately $28,000. Legacy Wealth Managment LLC ID boosted its position in CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the period. Finally, Main Street Group LTD bought a new stake in CME Group during the first quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors.

Insider Transactions at CME Group

In related news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on CME. The Goldman Sachs Group lowered their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Bank of America upped their price objective on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a report on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $286.00 to $270.00 in a research note on Wednesday. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Finally, TD Cowen cut their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $288.56.

CME Group Price Performance

Shares of CME stock opened at $274.98 on Monday. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $98.88 billion, a PE ratio of 23.32, a price-to-earnings-growth ratio of 3.27 and a beta of 0.23. The stock has a 50 day moving average of $251.17 and a 200-day moving average of $279.57.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the company posted $2.96 earnings per share. CME Group’s quarterly revenue was up .8% on a year-over-year basis. On average, equities analysts predict that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is 44.11%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.